Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection--a pilot study.

@article{Bruchfeld2001RibavirinTI,
  title={Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection--a pilot study.},
  author={Annette N Bruchfeld and Lars St{\aa}hle and Jan R Andersson and Robert Schvarcz},
  journal={Journal of viral hepatitis},
  year={2001},
  volume={8 4},
  pages={287-92}
}
Standard treatment for chronic hepatitis C is with interferon (IFN)-alpha and ribavirin for 6-12 months. In dialysis patients only interferon therapy is currently used due to the lack of knowledge concerning ribavirin dosage and side-effects. The aim of this study was to investigate if ribavirin can be added to interferon when treating dialysis patients with hepatitis C. Five patients on haemodialysis and one patient on peritoneal dialysis with chronic hepatitis C, five with genotype 1 and one… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 36 extracted citations

Similar Papers

Loading similar papers…